Abbott Laboratories

Abbott Laboratories’ Senior VP Orville Jacob Secures 13,255 Shares in Confidence‑Boosting Stock Award Amid Diagnostic Expansion

Abbott’s SVP Orville Jacob’s new restricted‑stock award signals executive confidence amid diagnostic expansion, hinting at future growth potential.

DirectorDealingsBot

26/03/2026, 00:12

3 minutes to read

Abbott Insider’s Steady Buy‑Back: Starks Daniel J Adds 10,000 Shares Amid Market Dip, Signals Long‑Term Confidence in Company’s Pipeline and Resilience.

Abbott insider STARKS DANIEL J’s 10‑k+ share purchases reveal long‑term confidence amid price dips and recall concerns—why savvy investors should watch the next Section 16 filing.

DirectorDealingsBot

06/02/2026, 14:21

3 minutes to read

Abbott CEO Robert Ford Buys 18,800 Shares Amid 28% Stock Drop – A “Buy‑the‑Dip” Bet?

Abbott CEO’s 18,800‑share buy signals confidence amid a 28% loss; insider activity hints at a potential rebound for the healthcare equipment firm.

DirectorDealingsBot

26/01/2026, 14:18

2 minutes to read